Saturday, 31 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleAI Now Institute

Multilateralism

View original at ainowinstitute.org
AI Now Institute - Ai Policy Title: Multilateralism Date: 2026-02-12 14:42 Source: https://ainowinstitute.org/publications/multilateralism <div class="wp-block-buttons has-custom-font-size has-medium-font-size is-content-justification-left is-layout-flex wp-container-core-buttons-is-layout-51c3bbf5 wp-block-buttons-is-…
Opening lines of the source · AI Now Institute · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Meta focuses policy agenda on open-weight LLMs while avoiding questions about algorithmic harms on social media platforms like WhatsApp

    80% confidence
  • Corporate partnerships may become unsustainable in the long run as AI model usage scales and costs increase

    80% confidence
  • Meta has influenced how governments regulate AI by pushing for data privacy rules to be weakened against Big Tech

    80% confidence
  • Big Tech companies like Meta, Google, Anthropic, OpenAI, and Hugging Face are always present in policy spaces

    80% confidence
  • Big Tech companies see the Majority World as both a new market to increase revenues and as a source of data to train models

    80% confidence
  • The India AI Impact Summit should shift narrative towards feasible solutions away from grand ideas that may not be implemented

    80% confidence
  • African governments and Global Majority countries need to be intentional about pursuing feasible AI goals rather than lofty objectives

    80% confidence
  • AI Incident databases don't provide much context on issues outside the US, UK, EU, and other Western countries

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com